Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 10 September, 2019

Northern Trust Corp

Form 8.3 - AbbVie Inc

RNS Number : 8665L
Northern Trust Corporation
10 September 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

 Northern Trust Corporation

Company dealt in

 AbbVie Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

 Common Stock USD 0.01

Date of dealing

 9th  September  2019

 

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 21,093,736   1.43%

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 21,093,736   1.43%

 

             

 

* Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 545 securities into the relevant accounts.

 

 

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit ($)

BUY

1977

66.7

SELL

2976

66.7

SELL

127

66.53

BUY

51

66.5757

SELL

81

66.7

SELL

27

66.5709

SELL

93

66.53

SELL

146

66.9124

SELL

51

66.9124

SELL

134

66.7

SELL

39

66.9124

SELL

39

66.9124

SELL

39

66.9124

SELL

31

66.7

BUY

11

66.7

SELL

47

66.5709

BUY

83

66.5757

SELL

34

66.5709

BUY

234

66.8043

BUY

1229

66.9256

SELL

80

66.94

SELL

46

66.5709

SELL

38

66.95

SELL

67

66.5709

SELL

42

66.5709

BUY

200

66.5757

BUY

76

66.9256

SELL

63

66.93

BUY

45

66.5757

BUY

96

66.5757

SELL

16

66.5709

SELL

23

66.5709

SELL

94

66.5709

BUY

59

66.5757

BUY

23

66.5757

BUY

37

66.5757

SELL

47

66.5709

BUY

105

66.5757

SELL

6

66.7

SELL

97

66.5709

BUY

25

66.5757

BUY

26

66.5757

SELL

21

66.5709

BUY

34

66.5757

BUY

58

66.5757

BUY

9

66.5757

SELL

20

66.5709

BUY

380

66.5757

SELL

663

66.9157

BUY

62

66.5757

SELL

42

66.5709

SELL

10

66.93

SELL

99

66.5709

BUY

812

66.8043

BUY

807

66.8043

BUY

261

66.755

BUY

31

66.5757

BUY

98

66.5757

BUY

77

66.5757

SELL

49

66.5709

SELL

37

66.79

SELL

95

66.9124

SELL

1695

66.67

SELL

150

66.49

SELL

80

66.87

BUY

25

66.84

BUY

10

66.86

BUY

94

66.7

SELL

82

66.82

BUY

10

66.92

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            NO

 

Date of disclosure

 10th  September 2019

Contact name

Frances McIlrath

Telephone number

0207 982 3386

If a connected EFM, name of offeree/offeror with which connected

 

 

If a connected EFM, state nature of connection (Note 10)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEURASRKOAKAAR

a d v e r t i s e m e n t